Vaccination with recombinant adenovirus encoding melanoma antigen delayed tumor growth in 30%–40% of mice, while vaccination in combination with anti-CD40 and anti-CTLA-4 mAbs induced complete response [108]. This evidence concerns the gene CTLA4 and neoplasm.